Fetal origins of neonatal lung disease: Understanding the pathogenesis of bronchopulmonary dysplasia

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 301, Issue 6, 2011, Pages

  Mestan, Karen K ^a   Steinhorn, Robin H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FETUS LUNG; HUMAN; INTRAUTERINE GROWTH RETARDATION; LUNG DISEASE; LUNG DYSPLASIA; NONHUMAN; PATHOGENESIS; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; PULMONARY ARTERY ENDOTHELIAL CELL DYSFUNCTION; PULMONARY HYPERTENSION;

ANIMALS; ENDOTHELIAL CELLS; FEMALE; FETAL GROWTH RETARDATION; PREGNANCY; PULMONARY ALVEOLI; PULMONARY ARTERY; SHEEP;

EID: 82855167233     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00314.2011     Document Type: Article

References (27)

1. An HS, Bae EJ, Kim GB, Kwon BS, Beak JS, Kim EK, Kim HS, Choi JH, Noh CI, Yun YS. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J 40: 131-136, 2010.
2. Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol 18: 1-9, 2001.
3. Barker DJ. Maternal nutrition and cardiovascular disease. Nutr Health 9: 99-106, 1993.
4. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 341: 938-941, 1993.
5. Bose C, Van Marter LJ, Laughon M, O'Shea TM, Allred EN, Karna P, Ehrenkranz RA, Boggess K, Leviton A. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics 124: e450-e458, 2009.
6. Braems G. Fetal hypoxemia on a molecular level: adaptive changes in the hypothalamic-pituitary-adrenal (HPA) axis and the lungs. Eur J Obstet Gynecol Reprod Biol 110, Suppl 1: S63-S69, 2003.
7. Cheah FC, Jobe AH, Moss TJ, Newnham JP, Kallapur SG. Oxidative stress in fetal lambs exposed to intra-amniotic endotoxin in a chorioamnionitis model. Pediatr Res 63: 274-279, 2008.
8. Chen B, Calvert AE, Cui H, Nelin LD. Hypoxia promotes human pulmonary artery smooth muscle cell proliferation through induction of arginase. Am J Physiol Lung Cell Mol Physiol 297: L1151-L1159, 2009.
9. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, Carmeliet P. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8: 702-710, 2002.
10. Farquhar M, Fitzgerald DA. Pulmonary hypertension in chronic neonatal lung disease. Paediatr Respir Rev 11: 149-153, 2010.
11. Grover TR, Parker TA, Zenge JP, Markham NE, Kinsella JP, Abman SH. Intrauterine hypertension decreases lung VEGF expression and VEGF inhibition causes pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 284: L508-L517, 2003.
12. Hoyert DL, Mathews TJ, Menacker F, Strobino DM, Guyer B. Annual summary of vital statistics: 2004. Pediatrics 117: 168-183, 2006.
13. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 46: 641-643, 1999.
14. Joss-Moore LA, Albertine KH, Lane RH. Epigenetics and the developmental origins of lung disease. Mol Genet Metab 104: 61-66, 2011.
15. Kanaka-Gantenbein C. Fetal origins of adult diabetes. Ann NY Acad Sci 1205: 99-105, 2010.
16. Lal MK, Manktelow BN, Draper ES, Field DJ. Chronic lung disease of prematurity and intrauterine growth retardation: a population-based study. Pediatrics 111: 483-487, 2003.
17. Law CM, Barker DJ, Richardson WW, Shiell AW, Grime LP, Armand-Smith NG, Cruddas AM. Thinness at birth in a northern industrial town. J Epidemiol Community Health 47: 255-259, 1993.
18. Lipsett J, Tamblyn M, Madigan K, Roberts P, Cool JC, Runciman SI, McMillen IC, Robinson J, Owens JA. Restricted fetal growth and lung development: a morphometric analysis of pulmonary structure. Pediatr Pulmonol 41: 1138-1145, 2006.
19. Maritz GS, Cock ML, Louey S, Joyce BJ, Albuquerque CA, Harding R. Effects of fetal growth restriction on lung development before and after birth: a morphometric analysis. Pediatr Pulmonol 32: 201-210, 2001.
20. Reiss I, Landmann E, Heckmann M, Misselwitz B, Gortner L. Increased risk of bronchopulmonary dysplasia and increased mortality in very preterm infants being small for gestational age. Arch Gynecol Obstet 269: 40-44, 2003.
21. Rozance PJ, Seedorf GJ, Brown A, Roe G, O'Meara MC, Gien J, Tang J, Abman SH. Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep. Am J Physiol Lung Cell Mol Physiol 301: L860-L871, 2011.
22. Slaughter JL, Pakrashi T, Jones DE, South AP, Shah TA. Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation. J Perinatol 31: 635-640, 2011.
23. Tamashiro KL, Moran TH. Perinatal environment and its influences on metabolic programming of offspring. Physiol Behav 100: 560-566, 2010.
24. Thompson JA, Regnault TR. In utero origins of adult insulin resistance and vascular dysfunction. Semin Reprod Med 29: 211-224, 2011.
25. Xita N, Tsatsoulis A. Fetal origins of the metabolic syndrome. Ann NY Acad Sci 1205: 148-155, 2010.
26. Zeitlin J, El Ayoubi M, Jarreau PH, Draper ES, Blondel B, Kunzel W, Cuttini M, Kaminski M, Gortner L, Van Reempts P, Kollee L, Papiernik E. Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort. J Pediatr 157: 733-739 e731, 2010.
27. Zhan CY, Yuan TM, Sun Y, Yu HM. Early gestational intrauterine infection induces postnatal lung inflammation and arrests lung development in a rat model. J Matern Fetal Neonatal Med 24: 213-222, 2011.